Clinical Trials
17
Active:13
Completed:2
Trial Phases
3 Phases
Phase 1:13
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
13 (81.3%)Phase 3
2 (12.5%)Phase 2
1 (6.3%)Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- InDex Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT05404074
- Locations
- 🇸🇪
CTC, Clinical Trial Consultants AB, Uppsala, Sweden
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
Phase 3
Terminated
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- InDex Pharmaceuticals
- Target Recruit Count
- 171
- Registration Number
- NCT04985968
- Locations
- 🇺🇸
Amicis Research Center, Granada Hills, California, United States
🇺🇸Allameh Medical Corporation, Mission Viejo, California, United States
🇺🇸Prospective Research Innovations Inc., Rancho Cucamonga, California, United States
The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
- First Posted Date
- 2017-06-07
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- InDex Pharmaceuticals
- Target Recruit Count
- 213
- Registration Number
- NCT03178669
- Locations
- 🇨🇿
1, Prague, Czechia
🇫🇷2, Amiens, France
🇫🇷3, Caen, France
The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- InDex Pharmaceuticals
- Target Recruit Count
- 131
- Registration Number
- NCT01493960
- Locations
- 🇨🇿
Site 402, Hradec Kralove, Czechia
🇨🇿Site 404, Hradec Kralove, Czechia
🇨🇿Site 406, Ostrava, Czechia
News
No news found